OptiNose OPTN 深 沪
已收盘 05-21 16:00:00 美东时间
9.60
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 9.60
- 总市值 9722.30万
- 52周最高 9.75
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.321
- 委 比 0.00%
- 总股本 1012.74万
- 历史最高 30.00
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.321
- 每 手 1
- 风险率 0.18%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BioVie分拆的肝病药企Option Therapeutics(OPTN.US)缩减IPO规模 下调募资额20%至2000万美元
周一，从BioVie分拆出来的临床二期肝病生物技术公司Option Therapeutics(OPTN.US)缩减了其即将进行的IPO的规模。
03-17 15:21
BRIEF-Option Therapeutics Inc - Now Sees IPO Of 1.8 Million Shares Of Common Stock - SEC Filing
BRIEF-Option Therapeutics Inc - Now Sees IPO Of 1.8 Million Shares Of Common Stock - SEC Filing March 16 (Reuters) - OPTION THERAPEUTICS INC - NOW SEES IPO OF 1.8 MILLION SHARES OF COMMON STOCK - SEC FILING Source text: [ID:n0001520138-26-000074] Further company coverage: [ ] (((( Reuters.Briefs@tho
03-16 18:36
BioVie拆分肝病业务 Option Therapeutics(OPTN.US)启动美股IPO
Option Therapeutics计划以每股10美元至12美元的价格区间发行230万股普通股。
01-27 15:21
Optinose Acquired by Paratek Pharmaceuticals for $330 Million
Optinose ( ($OPTN) ) has provided an update. Optinose, a company involved in th...
2025-05-21 20:57
美股大行评级 | 摩根大通：维持网易"超配"评级，目标价升至135美元；瑞银上调达美航空评级至"买入"
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1131517965561573377.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持Armata Pharmaceuticals(ARMP)"买入"评级，目标价从7美元升至9美元</p> <p>• 瑞银：维持爱芬奇(ANF)"买入"评级，目标价从115美
2025-05-20 09:28
HC Wainwright & Co. Reiterates Neutral on OptiNose, Maintains $9 Price Target
HC Wainwright & Co. analyst Matthew Caufield reiterates OptiNose (NASDAQ:OPTN) with a Neutral and maintains $9 price target.
2025-05-19 18:39
Optinose Stockholders Approve Merger with Paratek
Optinose ( ($OPTN) ) just unveiled an update. On May 16, 2025, OptiNose, Inc. h...
2025-05-17 00:57
OptiNose Inc <OPTN.OQ> expected to post a loss of 74 cents a share - Earnings Preview
OptiNose Inc OPTN.OQ OPTN.O is expected to show a rise in quarterly revenue when it reports results on May 12 (estimated) for the period ending March 31 2025 The Yardley Pennsylvania-based company is ...
2025-05-09 23:50
OptiNose Inc. Files Amendment to 10-K Annual Report
OptiNose Inc. filed an amendment to the 10-K annual report for the financial year ended December 31, 2024. The full filing can be accessed through the link below. Disclaimer: This news brief was creat...
2025-05-01 04:37
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPTN, COOP, MESA on Behalf of Shareholders
NEW YORK, April 9, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
2025-04-10 00:32
